Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Sanofi-Aventis Groupe

Home Clinical Trial Sponsors and OrganizationsSanofi-Aventis Groupe

Sanofi-Aventis Groupe

174 AVENUE DE FRANCE, Paris, Île-de-France, France

Part of Sanofi

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

148

148 active

Approvals

16

Total approvals

Agencies

3

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

110

74.3%

Trial Status Distribution

Active, not recruiting

148

100.0%

Clinical Trials

Trials sponsored by this organization (148)

Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety inPatients with Asthma (Long-Term Follow-Up)

Active, not recruiting

The effect of dupilumab on lung function and related changes in airway volumes detectable by functional respiratory imaging in patients with moderate-severe asthma

Active, not recruiting

Apr 2022340 participants

Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients with Non-Hodgkin’s Lymphoma and Acute Leukemia

Active, not recruiting

SAR231893-LPS15497- Dupilumab effect on Sleep in AD patients

Active, not recruiting

Jun 2021188 participants

Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated with Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent

Active, not recruiting

Jun 2021270 participants

The effect of dupilumab on lung function and related changes in airway volumes detectable by functional respiratory imaging in patients with moderate-severe asthma

Active, not recruiting

Jun 2021340 participants

A Real World Trial to determine efficacy and health outcomes of TOUJEO compared to standard of care basal insulin in patients already using basal insulin.

Active, not recruiting

May 2021609 participants

Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients with Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and are Treated with Insulin (ODYSSEY DM - Insulin)

Active, not recruiting

May 2021517 participants

Page 1 of 19

Approvals

Approvals by Agency

NMPA

National Medical Products Administration

4

Approvals

EMA

European Medicines Agency

4

Approvals

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

8

Approvals

Recent Approvals

Dupilumab Injection

COAPROVEL 300 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

DUOPLAVIN 75 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Irbesartan and Hydrochlorothiazide Tablets

Clopidogrel Bisulfate Tablets

COAPROVEL 300 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

COAPROVEL 300 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

AUBAGIO 14 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

JEVTANA 60 MG CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION

Rasburicase for injection

News

No news articles found

On this page

Overview
Clinical Trials148
Approvals16
News

Back to Organizations